Cargando…

Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study

PURPOSE: Medication non-adherence is a huge concern for the medical community. For chronic, especially neurological diseases, taking medication is a central pillar of treatment. To improve adherence to these oftentimes complex medication regimens, the construct needs to be understood in more depth....

Descripción completa

Detalles Bibliográficos
Autores principales: Franke, Gabriele Helga, Nentzl, Julia, Jagla-Franke, Melanie, Prell, Tino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253891/
https://www.ncbi.nlm.nih.gov/pubmed/34234417
http://dx.doi.org/10.2147/PPA.S311946
_version_ 1783717612367118336
author Franke, Gabriele Helga
Nentzl, Julia
Jagla-Franke, Melanie
Prell, Tino
author_facet Franke, Gabriele Helga
Nentzl, Julia
Jagla-Franke, Melanie
Prell, Tino
author_sort Franke, Gabriele Helga
collection PubMed
description PURPOSE: Medication non-adherence is a huge concern for the medical community. For chronic, especially neurological diseases, taking medication is a central pillar of treatment. To improve adherence to these oftentimes complex medication regimens, the construct needs to be understood in more depth. The aim of this study was to investigate associations between adherence with sociodemographics, clinical variables, and coping in neurological patients. PATIENTS AND METHODS: The sample consisted of 545 patients from a German neurological clinic. Adherence was assessed with the Stendal Adherence to Medication Score (SAMS). Patients were grouped as completely adherent (SAMS = 0), non-adherent (upper 25% of the sample), and moderately adherent. Associations with coping were assessed using the Essen Coping Questionnaire. RESULTS: Medication adherence was low compared to other non-neurological patient samples. Differences between adherence groups were found regarding gender and facets of coping, namely “trivialisation, wishful thinking and defence” and “finding of inner stability”. CONCLUSION: Interventions to improve medication adherence should focus on facets of coping with disease, increasing acceptance of disease, willpower, and confidence in treatment.
format Online
Article
Text
id pubmed-8253891
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82538912021-07-06 Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study Franke, Gabriele Helga Nentzl, Julia Jagla-Franke, Melanie Prell, Tino Patient Prefer Adherence Original Research PURPOSE: Medication non-adherence is a huge concern for the medical community. For chronic, especially neurological diseases, taking medication is a central pillar of treatment. To improve adherence to these oftentimes complex medication regimens, the construct needs to be understood in more depth. The aim of this study was to investigate associations between adherence with sociodemographics, clinical variables, and coping in neurological patients. PATIENTS AND METHODS: The sample consisted of 545 patients from a German neurological clinic. Adherence was assessed with the Stendal Adherence to Medication Score (SAMS). Patients were grouped as completely adherent (SAMS = 0), non-adherent (upper 25% of the sample), and moderately adherent. Associations with coping were assessed using the Essen Coping Questionnaire. RESULTS: Medication adherence was low compared to other non-neurological patient samples. Differences between adherence groups were found regarding gender and facets of coping, namely “trivialisation, wishful thinking and defence” and “finding of inner stability”. CONCLUSION: Interventions to improve medication adherence should focus on facets of coping with disease, increasing acceptance of disease, willpower, and confidence in treatment. Dove 2021-06-28 /pmc/articles/PMC8253891/ /pubmed/34234417 http://dx.doi.org/10.2147/PPA.S311946 Text en © 2021 Franke et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Franke, Gabriele Helga
Nentzl, Julia
Jagla-Franke, Melanie
Prell, Tino
Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study
title Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study
title_full Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study
title_fullStr Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study
title_full_unstemmed Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study
title_short Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study
title_sort medication adherence and coping with disease in patients from a neurological clinic: an observational study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253891/
https://www.ncbi.nlm.nih.gov/pubmed/34234417
http://dx.doi.org/10.2147/PPA.S311946
work_keys_str_mv AT frankegabrielehelga medicationadherenceandcopingwithdiseaseinpatientsfromaneurologicalclinicanobservationalstudy
AT nentzljulia medicationadherenceandcopingwithdiseaseinpatientsfromaneurologicalclinicanobservationalstudy
AT jaglafrankemelanie medicationadherenceandcopingwithdiseaseinpatientsfromaneurologicalclinicanobservationalstudy
AT prelltino medicationadherenceandcopingwithdiseaseinpatientsfromaneurologicalclinicanobservationalstudy